Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score‐matched analysis
Journal of Hepato-Biliary-Pancreatic Sciences · 2024
DOI: 10.1002/jhbp.1352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Won-Gun Yun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Background
Although attempts of local treatment for isolated liver recurrence in patients with pancreatic ductal adenocarcinoma (PDAC) have increased, the efficacy remains unclear. Therefore, we aimed to evaluate the effect of local treatment for recurrent liver lesions after pancreatectomy on the survival of patients with PDAC.
Methods
Patients who were diagnosed with isolated liver recurrence after pancreatectomy at a high‐volume center were included. We classified these patients based on the treatment options after recurrence and performed propensity score matching to minimize confounding.
Results
Median with interquartile range survival after recurrence was significantly longer for patients who underwent local treatment for recurrent liver lesions plus chemotherapy (22.0 [17.0–29.0] months) than those treated with chemotherapy alone (13.0 [7.0–21.0] months, p = .027). In multivariate analysis, not only local treatment for recurrent liver lesions plus chemotherapy (hazard ratio [95% confidence interval], 0.55 [0.32–0.94]; p = .030) but also indicators for systemically controlled tumor such as late recurrence (0.57 [0.35–0.92]; p = .021), chemotherapy for ≥6 months (0.25 [0.15–0.42]; p < .001), and disease control by chemotherapy (0.36 [0.22–0.60]; p < .001) were identified as favorable prognostic factors.
Conclusions
PDAC patients with stable recurrent liver lesions should be considered a candidate for local treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Won-Gun Yun, Youngmin Han, Mirang Lee, Hye-Sol Jung, Wooil Kwon, Jin-Young Jang
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Yun, W. G., Han, Y., Lee, M., Cho, Y. J., Jung, H. S., Kwon, W., & Jang, J. Y. (2024). Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score‐matched analysis. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1352
Vancouver
Yun WG, Han Y, Lee M, Cho YJ, Jung HS, Kwon W, et al. Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score‐matched analysis. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1352
BibTeX
@article{Yun2024,
author = {Yun, Won-Gun and Han, Youngmin and Lee, Mirang and Cho, Young Jae and Jung, Hye-Sol and Kwon, Wooil and Jang, Jin-Young},
title = {Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score‐matched analysis},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2024},
doi = {10.1002/jhbp.1352}
}
EUVIMED